Hyafilia ME:DAM Prime

Hyafilia ME:DAM Prime is a fifth-generation hybrid dermal filler developed by CHA Meditech Co., Ltd., South Korea. Utilizing Low Temperature Stabilization Reaction (L.T.S.R.) technology, it combines the advantages of monophasic and biphasic fillers, resulting in a high-density hyaluronic acid gel with enhanced resilience and enzyme resistance. Designed for aesthetic applications, it effectively addresses medium to deep wrinkles and enhances facial contours.

Formulation

• Active Ingredients: Hyaluronic Acid (HA) 20 mg/ml, Lidocaine 0.3%

• Structure: Hybrid composition with 85% stabilized HA and 15% native HA

• Technology: L.T.S.R. for a finely packed molecular structure and high viscoelasticity

Indications

• Correction of medium to deep facial wrinkles

• Treatment of nasolabial folds and marionette lines

• Lip augmentation and contouring

• Enhancement of cheekbones and facial volume

• Hand rejuvenation

Benefits

• Immediate and natural-looking results with minimal discomfort due to lidocaine content

• High elasticity ensures uniform distribution and reduces the risk of lump formation

• Biodegradable and hypoallergenic, minimizing the risk of adverse reactions

• Long-lasting effects, maintaining aesthetic improvements for up to 9 months

Scope of Application

• Facial areas: Lips, nasolabial folds, marionette lines, cheeks, and perioral regions

• Hands: Volume restoration and rejuvenation

Duration of Effect

The aesthetic results typically last between 6 to 9 months, depending on individual factors such as skin type, lifestyle, and treatment area.

Packaging and Specifications

• Packaging: 1 pre-filled syringe × 1.0 ml per pack

• Needle Size: 27G

• Storage Conditions: Store in a cool, dry place away from direct sunlight